These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36580095)

  • 1. Predicting pathological complete response of neoadjuvant radiotherapy and targeted therapy for soft tissue sarcoma by whole-tumor texture analysis of multisequence MRI imaging.
    Miao L; Cao Y; Zuo L; Zhang H; Guo C; Yang Z; Shi Z; Jiang J; Wang S; Li Y; Wang Y; Xie L; Li M; Lu N
    Eur Radiol; 2023 Jun; 33(6):3984-3994. PubMed ID: 36580095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pathological complete response in locally advanced head and neck squamous cell carcinoma treated with neoadjuvant chemo-immunotherapy using volumetric multisequence MRI histogram analysis.
    Liu H; Zhu C; Wang X; Chen X; Li Z; Xian J
    Neuroradiology; 2024 Jun; 66(6):919-929. PubMed ID: 38503986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy.
    Peeken JC; Asadpour R; Specht K; Chen EY; Klymenko O; Akinkuoroye V; Hippe DS; Spraker MB; Schaub SK; Dapper H; Knebel C; Mayr NA; Gersing AS; Woodruff HC; Lambin P; Nyflot MJ; Combs SE
    Radiother Oncol; 2021 Nov; 164():73-82. PubMed ID: 34506832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
    Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
    Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging.
    Liu S; Wen L; Hou J; Nie S; Zhou J; Cao F; Lu Q; Qin Y; Fu Y; Yu X
    Abdom Radiol (NY); 2019 Aug; 44(8):2689-2698. PubMed ID: 31030244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer.
    Iafrate F; Ciccarelli F; Masci GM; Grasso D; Marruzzo F; De Felice F; Tombolini V; D'Ambrosio G; Magliocca FM; Cortesi E; Catalano C
    Eur Radiol; 2023 Feb; 33(2):854-862. PubMed ID: 35980431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
    Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
    Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Develop and validate a radiomics space-time model to predict the pathological complete response in patients undergoing neoadjuvant treatment of rectal cancer: an artificial intelligence model study based on machine learning.
    Peng J; Wang W; Jin H; Qin X; Hou J; Yang Z; Shu Z
    BMC Cancer; 2023 Apr; 23(1):365. PubMed ID: 37085830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI.
    Bostel T; Dreher C; Wollschläger D; Mayer A; König F; Bickelhaupt S; Schlemmer HP; Huber PE; Sterzing F; Bäumer P; Debus J; Nicolay NH
    Radiat Oncol; 2020 Jul; 15(1):171. PubMed ID: 32653003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of
    Chodyla M; Demircioglu A; Schaarschmidt BM; Bertram S; Bruckmann NM; Haferkamp J; Li Y; Bauer S; Podleska L; Rischpler C; Forsting M; Herrmann K; Umutlu L; Grueneisen J
    J Nucl Med; 2021 Mar; 62(3):348-353. PubMed ID: 32737246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.
    Gao Y; Kalbasi A; Hsu W; Ruan D; Fu J; Shao J; Cao M; Wang C; Eilber FC; Bernthal N; Bukata S; Dry SM; Nelson SD; Kamrava M; Lewis J; Low DA; Steinberg M; Hu P; Yang Y
    Phys Med Biol; 2020 Aug; 65(17):175006. PubMed ID: 32554891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative synthetic MRI for predicting locally advanced rectal cancer response to neoadjuvant chemoradiotherapy.
    Lian S; Liu H; Meng T; Ma L; Zeng W; Xie C
    Eur Radiol; 2023 Mar; 33(3):1737-1745. PubMed ID: 36380196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T
    Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
    J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
    PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.